Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

70031-70040 of 71826 results

Catalogue Number:

PX-TA1406

Category:

G

Olendalizumab Biosimilar – Anti-C5 mAb – Research Grade

Target: C5
Target Alias Name: Olendalizumab/ALXN1007/C5/anti-C5
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2-G4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1520

Category:

G

Olinvacimab Biosimilar – Anti-KDR/ VEGFR2 mAb – Research Grade

Target: KDR/ VEGFR2
Target Alias Name: Olinvacimab/SSS-23/TTAC-0001/tanibirumab/KDR/ VEGFR2/anti-KDR/ VEGFR2
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa-lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1960

Category:

G

Oloctinebart Biosimilar – Anti-Mac-2 antigen mAb – Research Grade

Target: Mac-2 antigen
Target Alias Name: anti-Mac-2 antigen/ Lectin L-29/ LGALS3/ Galactose-specific lectin 3/ 35 kDa lectin/ Galactoside-binding protein/ CBP 35/ L-31/ Gal-3/ Laminin-binding protein/ Galectin-3/ GALBP/ IgE-binding protein/ Carbohydrate-binding protein 35/ MAC2
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1247

Category:

G

Olokizumab Biosimilar – Anti-IL6 mAb – Research Grade

Target: IL6
Target Alias Name: Olokizumab/CDP 6038/IL6/anti-IL6
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1055

Category:

G

Omalizumab Biosimilar – Anti-IGHE mAb – Research Grade

Target: IGHE
Target Alias Name: Omalizumab/IGE25/olizumab/pSVIE26/rhuMab-E25/IGHE/anti-IGHE
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1532

Category:

G

Omburtamab Biosimilar – Anti-CD276/ B7-H3/ B7RP-2 mAb – Research Grade

Target: CD276/ B7-H3/ B7RP-2
Target Alias Name: Omburtamab/8H9/Mab 8H9/CD276/ B7-H3/ B7RP-2/anti-CD276/ B7-H3/ B7RP-2
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1694

Category:

G

Omodenbamab Biosimilar – Anti-SpA mAb – Research Grade

Target: SpA
Target Alias Name: Omodenbamab/514G3/IMMUNOGLOBULIN G3/ ANTI-(STAPHYLOCOCCAL PROTEIN A) (HUMAN MONOCLONAL 514G3 .GAMMA.3-CHAIN)/ DISULFIDE WITH HUMAN MONOCLONAL 514G3 .KAPPA.-CHAIN/ DIMER/SpA/anti-SpA
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG3/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA2130

Category:

G

Omoprubart Biosimilar – Anti-CPAMD4 mAb – Research Grade

Target: CPAMD4
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG2/G4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1260

Category:

G

Onartuzumab Biosimilar – Anti-MET/ RCCP2 mAb – Research Grade

Target: MET/ RCCP2
Target Alias Name: Onartuzumab/MetMAb/OA-5D5/PRO 143966/MET/ RCCP2/anti-MET/ RCCP2
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: Fab-G1-kappa -[Fc-G1]
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1115

Category:

G

Oncolym Biosimilar – Anti-HLA-DR10 mAb – Research Grade

Target: HLA-DR10
Target Alias Name: Oncolym/Iodine 131-ILym-1/Lym-1/Oncolym/HLA-DR10/anti-HLA-DR10
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2a-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression